News Medical on MSN
Researchers use genetic engineering to create “product-ready” snakebite antivenom
An international team of researchers has used genetic engineering to create the first ever “product-ready” antivenom for ...
We have written about the promise of gene therapy to correct genetic disease many times. An exciting development happened ...
3don MSN
Height secrets: Paediatric shares diet, hormone health tips to make your child taller and stronger
A child's healthy growth is a complex interplay of genetics, hormones and nutrition. Experts emphasize that factors like ...
This article examines key innovations driving scalable, high-yield purification of recombinant AAVs and how they’re helping ...
DENVER, Nov. 04, 2025 (GLOBE NEWSWIRE) -- 247marketnews.com, a pioneer in digital media dedicated to the swift distribution of financial market ...
Next-Generation Biopharmaceuticals Transforming the Global Therapeutic LandscapeThe Global Bio Pharmaceuticals Market is ...
Infection of genital epithelial cells with human papillomavirus (HPV) types 16 and 18 is closely associated with the development of cervical carcinoma. The transforming potential of these high-risk ...
Immunologist Zachary Rubin explains how the World Health Organization decides which strains of influenza end up in annual flu ...
October 21, 2025--(BUSINESS WIRE)--ABIONYX Pharma, (FR0012616852 - ABNX - PEA PME eligible), a new generation biotech company dedicated to the world's only recombinant apoA-I ... for the first time, ...
TipRanks on MSN
Tenaya Therapeutics Advances Genetic Therapy for Heart Disease: A Closer Look at the TN-201 Study
Tenaya Therapeutics, Inc. (($TNYA)) announced an update on their ongoing clinical study. Tenaya Therapeutics, Inc. is conducting a pivotal ...
CollPlant Biotechnologies (Nasdaq: CLGN), a regenerative and aesthetic medicine company developing innovative technologies ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results